Principal Capital Valuation

Is PRINC-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PRINC-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate PRINC-R's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PRINC-R's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PRINC-R?

Key metric: As PRINC-R is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PRINC-R. This is calculated by dividing PRINC-R's market cap by their current revenue.
What is PRINC-R's PS Ratio?
PS Ratio	1.8x
Sales	฿6.25b
Market Cap	฿11.43b

PRINC-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.3x
Enterprise Value/EBITDA	33.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does PRINC-R's PS Ratio compare to its peers?

The above table shows the PS ratio for PRINC-R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.1x
THG Thonburi Healthcare Group	1.5x	13.2%	฿13.5b
CMR Chiang Mai Ram Medical Business	1.3x	n/a	฿7.2b
TNH Thai Nakarin Hospital	2.4x	n/a	฿6.6b
SKR Sikarin	3.1x	n/a	฿19.3b
PRINC-R Principal Capital	1.8x	n/a	฿11.4b

Price-To-Sales vs Peers: PRINC-R is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (3x).

Price to Sales Ratio vs Industry

How does PRINC-R's PS Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Sales	Estimated Growth	Market Cap

No more companies available in this PS range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: PRINC-R is good value based on its Price-To-Sales Ratio (1.8x) compared to the TH Healthcare industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is PRINC-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PRINC-R PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1.8x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate PRINC-R's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Master Style

฿12.7b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿42.25

-8.2%

-7.1%

E for L Aim

฿1.1b

Engages in the distribution of medical devices and equipment in Thailand.

EFORL-R

฿0.28

3.7%

12.0%

Safe Fertility Group

฿3.6b

Provides fertility medical center services in Thailand.

SAFE

฿12.00

-0.8%

-33.0%